Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al
Battery voltage reflects how much energy is left
Prescription Weight Loss Pills Eligibility Private prescription: BMI 30+, or BMI 27+ with at least one weight-related comorbidity (PCOS, hypertension, dyslipidaemia, type 2 diabetes, sleep apnoea) NHS (Orlistat): BMI 30+, or BMI 28+ with additional risk factors NHS (GLP-1 injections via specialist services): BMI 35+ with at least one comorbidity Where injections win - Highest efficacy - Mounjaro and Wegovy 7.2mg injection currently outperform both oral options on average weight loss Already available in the UK Weekly dosing No fasting requirements When pills make more sense - Genuine needle phobia Frequent travel where cold storage is difficult Pills draw less attention than injectable pens You take levothyroxine and orforglipron suits your existing morning routine better than the Wegovy pill Well let you decide whats better
Osong Public Health Res
By the end of the decade the class had expanded from one twice-daily injectable to a portfolio of once-daily and once-weekly options and the weight-loss signal everyone had noticed in the diabetes trials was about to become its own indication
-Fits on Relumins Advanced Oral Glutathione vials
